コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 derwent in vivo 3-T MR spectroscopy prior to stereotactic biopsy.
2 opic MR imaging before surgical resection or stereotactic biopsy.
3 0% of the mammographic lesion was removed at stereotactic biopsy.
4 The patient underwent a stereotactic biopsy.
5 formation formed the basis for targeting the stereotactic biopsy.
6 e invaluable in the precise targeting of the stereotactic biopsy.
7 he lesion seen at mammography was removed at stereotactic biopsy.
8 ign of breast cancer and frequent target for stereotactic biopsy.
9 one (5%) of 21 lesions that yielded DCIS at stereotactic biopsy.
10 one (10%) of 10 lesions that yielded ADH at stereotactic biopsy.
11 le, and early neurosurgical consultation for stereotactic biopsy.
12 Calcifications were retrieved from all 113 stereotactic biopsies.
13 ed because of contraindications for invasive stereotactic biopsies.
15 restimates were lesions that yielded DCIS at stereotactic biopsy and infiltrating carcinoma at surger
16 for US guidance, 23% (95% CI: 19%, 27%) for stereotactic biopsy, and 32% (95% CI: 22%, 43%) for MRI
21 -situ, the use of fine-needle aspiration and stereotactic biopsy for diagnosis, and the use of neoadj
26 old woman underwent 11-gauge vacuum-assisted stereotactic biopsy of a cluster of indeterminate calcif
32 lar atrophy without white matter lesions and stereotactic biopsy showed selective infection of the ce
35 d were compared with a similar assessment of stereotactic biopsy specimens by using Kendall taub.
36 e clip was placed when images obtained after stereotactic biopsy suggested that the lesion seen at ma
37 neuropathologic evaluation of tissue from 88 stereotactic biopsies, supplemented with (18)F-FET PET a
39 ds All calcifications (n = 2359) for which a stereotactic biopsy was performed from 2008 through 2015
41 review was performed of 135 lesions in which stereotactic biopsy was performed with a directional, va